Semi-Annual Balance Sheet

Carna Biosciences, Inc. - Filing #7712030

Concept As at
2019-03-31
As at
2018-12-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,180,608,000 JPY
1,355,254,000 JPY
Other
118,023,000 JPY
117,671,000 JPY
Current assets
1,505,095,000 JPY
1,671,589,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
21,178,000 JPY
18,729,000 JPY
Intangible assets
Intangible assets
170,000 JPY
183,000 JPY
Investments and other assets
Investments and other assets
74,522,000 JPY
79,587,000 JPY
Non-current assets
95,871,000 JPY
98,501,000 JPY
Assets
1,600,967,000 JPY
1,770,090,000 JPY
Liabilities
Current liabilities
Accounts payable - trade
224,000 JPY
478,000 JPY
Income taxes payable
8,293,000 JPY
19,399,000 JPY
Other
12,335,000 JPY
12,458,000 JPY
Current liabilities
327,786,000 JPY
400,139,000 JPY
Accounts payable - other
92,783,000 JPY
134,988,000 JPY
Non-current liabilities
Non-current liabilities
425,847,000 JPY
482,497,000 JPY
Bonds payable
102,000,000 JPY
116,000,000 JPY
Long-term borrowings
295,011,000 JPY
337,755,000 JPY
Asset retirement obligations
26,833,000 JPY
26,700,000 JPY
Other
2,002,000 JPY
2,041,000 JPY
Liabilities
753,633,000 JPY
882,636,000 JPY
Other liabilities
Other liabilities
Net assets
Share capital
3,691,074,000 JPY
3,591,568,000 JPY
Shareholders' equity
Capital surplus
Capital surplus
2,509,099,000 JPY
2,409,593,000 JPY
Retained earnings
Retained earnings
-5,354,296,000 JPY
-5,117,482,000 JPY
Treasury shares
-117,000 JPY
-117,000 JPY
Shareholders' equity
845,760,000 JPY
883,563,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-510,000 JPY
-758,000 JPY
Valuation and translation adjustments
-2,764,000 JPY
-3,326,000 JPY
Net assets
847,333,000 JPY
887,453,000 JPY
Share acquisition rights
4,336,000 JPY
7,216,000 JPY
Liabilities and net assets
1,600,967,000 JPY
1,770,090,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.